AGILON HEALTH ($AGL) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of -$0.46 per share, missing estimates of -$0.27 by $0.19. The company also reported revenue of $1,569,490,000, beating estimates of $1,475,982,892 by $93,507,108.
Stock price change since market close: -2.49%
You can see Quiver Quantitative's $AGL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AGILON HEALTH Insider Trading Activity
AGILON HEALTH insiders have traded $AGL stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AGL stock by insiders over the last 6 months:
- JOHN WILLIAM WULF purchased 81,000 shares for an estimated $50,940
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AGILON HEALTH Hedge Fund Activity
We have seen 103 institutional investors add shares of AGILON HEALTH stock to their portfolio, and 141 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC added 13,283,930 shares (+196.2%) to their portfolio in Q4 2025, for an estimated $9,148,642
- FMR LLC removed 12,762,898 shares (-81.6%) from their portfolio in Q4 2025, for an estimated $8,789,807
- D. E. SHAW & CO., INC. added 10,317,463 shares (+103.2%) to their portfolio in Q4 2025, for an estimated $7,105,636
- AQR CAPITAL MANAGEMENT LLC added 9,505,837 shares (+1346.6%) to their portfolio in Q4 2025, for an estimated $6,546,669
- CAPITAL INTERNATIONAL INVESTORS removed 8,232,209 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,669,522
- VANGUARD GROUP INC removed 5,970,795 shares (-24.6%) from their portfolio in Q4 2025, for an estimated $4,112,086
- MORGAN STANLEY removed 5,507,572 shares (-9.3%) from their portfolio in Q4 2025, for an estimated $3,793,064
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AGILON HEALTH Price Targets
Multiple analysts have issued price targets for $AGL recently. We have seen 2 analysts offer price targets for $AGL in the last 6 months, with a median target of $1.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $1.0 on 11/06/2025
- Stephen Baxter from Wells Fargo set a target price of $1.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
